Menopause

Prenatal Exposure to Famine Increases Risk for Early Menopause

Prenatal Exposure to Famine Increases Risk for Early Menopause

Fetal exposure to famine is associated with an increased risk for early menopause.

Urinary Incontinence Drug May Reduce Frequency of Hot Flashes

Urinary Incontinence Drug May Reduce Frequency of Hot Flashes

By

Oxybutynin, an anticholinergic used to treat urinary incontinence, may provide breast cancer survivors with an alternative treatment option for hot flashes, according to new research.

Menopausal Hormone Therapy May Reduce Carpal Tunnel Syndrome Risk

Menopausal Hormone Therapy May Reduce Carpal Tunnel Syndrome Risk

By

To investigate the association between hormone therapy and carpal tunnel syndrome risk, researchers conducted a secondary analysis of the Women's Health Initiative (WHI) hormone therapy trials.

Age-Related Vaginal Symptoms Associated With Worse Quality of Life

Age-Related Vaginal Symptoms Associated With Worse Quality of Life

Severe vulvovaginal atrophy (VVA) symptoms are associated with worse quality of life in postmenopausal women.

Sleep Quality in Women With Surgical vs Natural Menopause

Sleep Quality in Women With Surgical vs Natural Menopause

By

Women who undergo surgical menopause have significantly worse sleep quality than those who experience natural menopause.

Functional Disability Progression More Rapid in Postmenopausal Women With RA

Functional Disability Progression More Rapid in Postmenopausal Women With RA

Functional disability progressed more rapidly in postmenopausal compared with premenopausal women with rheumatoid arthritis.

High Circulating Prolactin Concentrations May Lower Risk for Type 2 Diabetes

High Circulating Prolactin Concentrations May Lower Risk for Type 2 Diabetes

By

High circulating total prolactin concentrations may be linked with a lower risk for type 2 diabetes in women.

Cardiometabolic Disease Patterns Related to Race, Ethnicity in Midlife Women

Cardiometabolic Disease Patterns Related to Race, Ethnicity in Midlife Women

By

Women entering menopause had patterns of cardiometabolic risk components related to race/ethnicity.

Early Natural Menopause Linked to Life Expectancy, Years With T2D

Early Natural Menopause Linked to Life Expectancy, Years With T2D

Compared with women who experience normal or late menopause, women who experience early natural menopause have a shorter life expectancy and spend fewer years without type 2 diabetes.

Atherosclerosis Progression Differs According to Timing of Estradiol Therapy After Menopause

Atherosclerosis Progression Differs According to Timing of Estradiol Therapy After Menopause

By

Higher levels of estradiol were inversely associated with carotid artery intima-media thickness progression in the early postmenopausal cohort but positively associated with it in the late postmenopausal group.

Weight Loss May Reduce Breast Cancer Risk in Postmenopausal Women

Weight Loss May Reduce Breast Cancer Risk in Postmenopausal Women

Postmenopausal women with weight loss have a reduced risk for breast cancer.

Light Therapy Offers Nonpharmacologic Treatment for Perimenopausal Depression

Light Therapy Offers Nonpharmacologic Treatment for Perimenopausal Depression

By

Light treatments successfully corrected abnormal timing of melatonin circadian rhythms in perimenopausal women with depression and improved mood and sleep within 2 weeks.

MicroRNAs Linked to Increased Cortical Bone Porosity in Postmenopausal Women With History of Fracture

MicroRNAs Linked to Increased Cortical Bone Porosity in Postmenopausal Women With History of Fracture

By

Findings suggest potential pathomechanistic links between miRNAs and cortical porosity. .

Bone Mineral Density Changes After Anastrozole in Postmenopausal Women

Bone Mineral Density Changes After Anastrozole in Postmenopausal Women

By

In postmenopausal women who were randomly assigned anastrozole, bone mineral density showed significant improvement at the lumbar spine.

Effects of Vitamin D3 Treatment on Bone Strength in Postmenopausal Women

Effects of Vitamin D3 Treatment on Bone Strength in Postmenopausal Women

By

Investigators sought to determine the effects of vitamin D3 supplementation in postmenopausal women with low serum 25(OH)D and high parathyroid hormone levels.

Physical Activity as a Lifestyle Factor Influencing Early Menopause

Physical Activity as a Lifestyle Factor Influencing Early Menopause

By

Researchers concluded that physical activity was not associated with risk for early menopause.

Guidelines for Managing Perimenopausal Depression Now Available

Guidelines for Managing Perimenopausal Depression Now Available

By

The 5 topics addressed by the 11-member expert panel include epidemiology, clinical presentation, therapeutic effects of antidepressants, effects of hormone therapy, and the effectiveness of other therapies (eg, psychotherapy, exercise, natural health products).

Characteristics of Menstrual Cycle Associated With Early Natural Menopause

Characteristics of Menstrual Cycle Associated With Early Natural Menopause

By

Investigators examined the relationship between menstrual cycle characteristics in adolescence and early adulthood and the risk for early natural menopause.

'Good' Cholesterol May Not Be Good in Postmenopausal Women

'Good' Cholesterol May Not Be Good in Postmenopausal Women

High total HDL cholesterol in postmenopausal women may mask heart disease risk.

Ectopic Lipid Deposition and Insulin Resistance Higher in Postmenopausal Women

Ectopic Lipid Deposition and Insulin Resistance Higher in Postmenopausal Women

By

The insulin sensitivity in post- and premenopausal women along with lipid deposition in the liver and skeletal muscle was examined.

Can Weight Gain After Smoking Cessation Be Reduced By Increasing Physical Activity in Postmenopausal Women?

Can Weight Gain After Smoking Cessation Be Reduced By Increasing Physical Activity in Postmenopausal Women?

By

Investigators examined whether increase in physical activity may reduce weight gain after smoking cessation in postmenopausal women.

Effects of Menopause on Prolactinoma Treatment Outcomes Post-Dopamine Agonist Withdrawal

Effects of Menopause on Prolactinoma Treatment Outcomes Post-Dopamine Agonist Withdrawal

By

Serum prolactin level 6 to 12 months after dopamine agonist withdrawal may be a useful predictor for clinical outcomes in patients with prolactinoma.

No Additional Benefits With Vaginal Estradiol Tablets, Moisturizers for Postmenopausal Vulvovaginal Symptoms

No Additional Benefits With Vaginal Estradiol Tablets, Moisturizers for Postmenopausal Vulvovaginal Symptoms

By

Prescribed vaginal estradiol tablets and over-the-counter vaginal moisturizers may not be more effective than placebos for postmenopausal vulvovaginal symptoms.

Nutraceuticals Containing Equol May Be Effective for Postmenopausal Symptoms

Nutraceuticals Containing Equol May Be Effective for Postmenopausal Symptoms

By

Equol-containing nutraceuticals may be beneficial for postmenopausal women with vaginal symptoms.

Many Women Report Vasomotor Symptoms in Their 60s

Many Women Report Vasomotor Symptoms in Their 60s

Symptoms more likely in those reporting fair health, history of non-spontaneous menopause

Menopausal Hormone Therapy Slows Cognitive Decline in Postmenopausal Women

Menopausal Hormone Therapy Slows Cognitive Decline in Postmenopausal Women

By

Menopausal hormone therapy may slow cognitive decline in postmenopausal women with mild cognitive impairment.

Romosozumab Followed by Denosumab Effective for BMD Increase in Postmenopausal Women

Romosozumab Followed by Denosumab Effective for BMD Increase in Postmenopausal Women

By

Romosozumab increased bone mineral density in postmenopausal women through increased bone formation and decreased bone resorption.

Sex Hormone Levels May Affect Postmenopausal Heart Disease Risk

Sex Hormone Levels May Affect Postmenopausal Heart Disease Risk

By

Researchers assessed the effect of testosterone, estradiol, dehydroepiandrosterone, and sex hormone-binding globulin levels on coronary heart disease, heart failure, and cardiovascular disease in postmenopausal women.

Imvexxy Approved for Moderate to Severe Dyspareunia Due to Menopause

Imvexxy Approved for Moderate to Severe Dyspareunia Due to Menopause

By

The FDA approval was supported by findings from a Phase 3, randomized, double-blind, placebo-controlled study that evaluated Imvexxy (4mcg and 10mcg) vs placebo from baseline to week 12.

Asthma Risk Increased for Premenopausal Women Using Oral Contraceptives

Asthma Risk Increased for Premenopausal Women Using Oral Contraceptives

By

Oral contraceptive use in women of reproductive age may increase the risk for lifetime asthma.

Sign Up for Free e-Newsletters



CME Focus